|Weighted event rates|
|Patients||Number of trials (n)||Statins||Control||RRR (95% CI)||NNT (CI)|
|*CHD = coronary heart disease; other abbreviations defined in glossary. RRR, NNT, and CI calculated from data in article using a random effects model. Patients in 6 of the 29 statin trials could not be classified as having or not having CHD because 10–90% of patients had CHD.|
|With and without CHD||29 (93 399)||3.2%||3.6%||18% (10 to 24)||220 (140 to 504)|
|With CHD||17 (25 718)||2.6%||3.2%||25% (13 to 35)||190 (112 to 634)|
|Without CHD||6 (19 567)||1.4%||1.9%||23% (5 to 38)||159 (129 to 1667)|
Review: statins reduce non-fatal and fatal strokes in patients with and without coronary heart disease
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>
EBN Online Journal Club
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.